Charles River Laboratories International (CRL) Total Non-Current Liabilities (2009 - 2025)

Charles River Laboratories International's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $3.8 billion for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities fell 1.02% year-over-year to $3.8 billion; the TTM figure through Dec 2025 stood at $3.8 billion (down 1.02% YoY), while the FY2025 annual figure was $3.8 billion, down 1.02% from the prior year.
• Total Non-Current Liabilities was $3.8 billion for Q4 2025 at Charles River Laboratories International, down from $3.9 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $4.6 billion in Q2 2022 to a low of $3.4 billion in Q1 2021.
• Historically, Total Non-Current Liabilities has averaged $4.1 billion across 5 years, with a median of $4.2 billion in 2021.
• The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities jumped 33.34% in 2021, then decreased 11.31% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $4.2 billion in 2021, then advanced by 5.13% to $4.4 billion in 2022, then declined by 2.08% to $4.3 billion in 2023, then decreased by 11.31% to $3.8 billion in 2024, then slipped by 1.02% to $3.8 billion in 2025.
• The last three Total Non-Current Liabilities figures came in at $3.8 billion (Q4 2025), $3.9 billion (Q3 2025), and $4.0 billion (Q2 2025), per Business Quant data.